Mark Hartmann
Impact in
- Physiology top 5%
- Nitric Oxide and Endothelin Effects
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
Papers in
-
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 5
- Cancer-related gene regulation 3
- Ubiquitin and proteasome pathways 1
-
- Acute Myeloid Leukemia Research 3
- Co-authors
- Thomas Münzel (3 shared papers)Thomas Meinertz (3 shared papers)Hanke Mollnau (3 shared papers)Ascan Warnholtz (3 shared papers)Ulrich Förstermann (3 shared papers)Mathias Oelze (3 shared papers)Huige Li (2 shared papers)Ulrich Hink (2 shared papers)
- Journals
- International Journal of Cancer (2 papers)Circulation Research (2 papers)Clinical Cancer Research (1 paper)Experimental Hematology (1 paper)Blood (1 paper)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
Mark Hartmann
15 papers receiving 1.6k citations
Mark Hartmann's Hit Papers
Peers
Comparison fields: 5 of 89
- Physiology 663
- Clinical Biochemistry 164
- Biochemistry 180
- Cardiology and Cardiovascular Medicine 314
- Immunology 220
Countries citing papers authored by Mark Hartmann
This map shows the geographic impact of Mark Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hartmann more than expected).
Fields of papers citing papers by Mark Hartmann
This network shows the impact of papers produced by Mark Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hartmann. The network helps show where Mark Hartmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Hartmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus Hit paper breakdown → | 2001 | 1016 |
| 2 | 2000 | 196 | |
| 3 | 2017 | 140 | |
| 4 | 2015 | 81 | |
| 5 | 2018 | 60 | |
| 6 | 2000 | 37 | |
| 7 | 2020 | 33 | |
| 8 | 2022 | 16 | |
| 9 | 2017 | 11 | |
| 10 | 2024 | 8 | |
| 11 | 2018 | 4 | |
| 12 | Max-Balanced Flows | 1990 | 2 |
| 13 | 2022 | 1 | |
| 14 | 2020 | 1 | |
| 15 | 2018 | 1 |
About Mark Hartmann
Mark Hartmann is a scholar working on Molecular Biology, Hematology, Physiology, Immunology and Cancer Research, having authored 15 papers that have together received 1.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (5 papers), Acute Myeloid Leukemia Research (3 papers), Nitric Oxide and Endothelin Effects (3 papers), Cancer-related gene regulation (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Ubiquitin and proteasome pathways (1 paper) and Eicosanoids and Hypertension Pharmacology (1 paper). The work is most often cited by research in Physiology (663 citations), Clinical Biochemistry (164 citations), Biochemistry (180 citations), Cardiology and Cardiovascular Medicine (314 citations) and Immunology (220 citations). Mark Hartmann has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Thomas Münzel, Thomas Meinertz, Hanke Mollnau, Ascan Warnholtz, Ulrich Förstermann, Mathias Oelze, Huige Li, Ulrich Hink, M. Skatchkov and David G. Harrison. Their work appears in journals such as International Journal of Cancer, Circulation Research, Clinical Cancer Research, Experimental Hematology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.